Evidence map›Paper›PMID 40734972›Full record

ArticleGynecologic oncology reports2025

Complete response of somatic

Natasha E Charewycz, I-Chow Joe Hsu, Kevin Lu, Katherine Fuh, Lee-May Chen, Varun Monga, Stephanie Cham

Abstract readCase Reports
In one paragraph

Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Integrated mutational landscape analysis of endometrial stromal sarcoma.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Natasha E CharewyczThe University of Vermont Robert Larner College of Medicine, United States.
I-Chow Joe HsuUniversity of California San Francisco, Department of Radiation Oncology, United States.
Kevin LuUniversity of California San Francisco, Department of Pathology, United States.
Katherine FuhUniversity of California San Francisco, Obstetrics Gynecology & Reproductive Sciences, Division of Gynecologic Oncology, United States.
Lee-May ChenUniversity of California San Francisco, Obstetrics Gynecology & Reproductive Sciences, Division of Gynecologic Oncology, United States.
Varun MongaUniversity of California San Francisco, Department of Medicine, Division of Hematology and Oncology, United States.
Stephanie ChamUniversity of California San Francisco, Obstetrics Gynecology & Reproductive Sciences, Division of Gynecologic Oncology, United States.

Funding

WOMEN'S REPRODUCTIVE HEALTH RESEARCH CENTERK12HD001262 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Andrea Vashti Jackson · 1998 to 2026
$9.3M
NICHD NIH HHS K12 HD001262
6 · The paper itself

Abstract

Objectives: To discuss the role of immunotherapy and concurrent radiotherapy in the treatment of Methods: We present the case of a woman with rapidly recurrent Results: A 67-year-old woman diagnosed with stage IB UUS underwent surgical resection with negative margins and experienced rapid locoregional recurrence within six weeks. Next-generation sequencing (NGS) identified a somatic Conclusions: To our knowledge, this is the first reported case of a

Identifiers

PMID40734972
PMCPMC12305609

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.